vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and SunCoke Energy, Inc. (SXC). Click either name above to swap in a different company.

CLARIVATE PLC is the larger business by last-quarter revenue ($617.0M vs $480.2M, roughly 1.3× SunCoke Energy, Inc.). CLARIVATE PLC runs the higher net margin — 0.5% vs -17.8%, a 18.3% gap on every dollar of revenue. On growth, SunCoke Energy, Inc. posted the faster year-over-year revenue change (-1.2% vs -6.9%). CLARIVATE PLC produced more free cash flow last quarter ($89.2M vs $32.8M). Over the past eight quarters, CLARIVATE PLC's revenue compounded faster (-0.3% CAGR vs -0.8%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

Energy Brands, also doing business as Glacéau, is a privately owned subsidiary of the Coca-Cola Company based in Whitestone, Queens, New York, that manufactures and distributes various lines of drinks marketed as enhanced water. Founded in May 1996 by J. Darius Bikoff with an electrolyte enhanced line of water called Smartwater, Energy Brands initially distributed its products to health food stores and independent retailers in the New York area. Adding Fruitwater and Vitaminwater to its line ...

CLVT vs SXC — Head-to-Head

Bigger by revenue
CLVT
CLVT
1.3× larger
CLVT
$617.0M
$480.2M
SXC
Growing faster (revenue YoY)
SXC
SXC
+5.7% gap
SXC
-1.2%
-6.9%
CLVT
Higher net margin
CLVT
CLVT
18.3% more per $
CLVT
0.5%
-17.8%
SXC
More free cash flow
CLVT
CLVT
$56.4M more FCF
CLVT
$89.2M
$32.8M
SXC
Faster 2-yr revenue CAGR
CLVT
CLVT
Annualised
CLVT
-0.3%
-0.8%
SXC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLVT
CLVT
SXC
SXC
Revenue
$617.0M
$480.2M
Net Profit
$3.1M
$-85.6M
Gross Margin
66.8%
Operating Margin
6.7%
-20.4%
Net Margin
0.5%
-17.8%
Revenue YoY
-6.9%
-1.2%
Net Profit YoY
101.6%
-461.2%
EPS (diluted)
$0.00
$-1.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
SXC
SXC
Q4 25
$617.0M
$480.2M
Q3 25
$623.1M
$487.0M
Q2 25
$621.4M
$434.1M
Q1 25
$593.7M
$436.0M
Q4 24
$663.0M
$486.0M
Q3 24
$622.2M
$490.1M
Q2 24
$650.3M
$470.9M
Q1 24
$621.2M
$488.4M
Net Profit
CLVT
CLVT
SXC
SXC
Q4 25
$3.1M
$-85.6M
Q3 25
$-28.3M
$22.2M
Q2 25
$-72.0M
$1.9M
Q1 25
$-103.9M
$17.3M
Q4 24
$-191.8M
$23.7M
Q3 24
$-65.6M
$30.7M
Q2 24
$-304.3M
$21.5M
Q1 24
$-75.0M
$20.0M
Gross Margin
CLVT
CLVT
SXC
SXC
Q4 25
66.8%
Q3 25
65.0%
Q2 25
67.2%
Q1 25
65.1%
Q4 24
65.7%
Q3 24
66.2%
Q2 24
67.2%
Q1 24
64.9%
Operating Margin
CLVT
CLVT
SXC
SXC
Q4 25
6.7%
-20.4%
Q3 25
7.1%
2.8%
Q2 25
1.1%
2.3%
Q1 25
-3.5%
6.9%
Q4 24
-9.4%
7.3%
Q3 24
3.5%
9.6%
Q2 24
-36.9%
7.4%
Q1 24
0.8%
7.1%
Net Margin
CLVT
CLVT
SXC
SXC
Q4 25
0.5%
-17.8%
Q3 25
-4.5%
4.6%
Q2 25
-11.6%
0.4%
Q1 25
-17.5%
4.0%
Q4 24
-28.9%
4.9%
Q3 24
-10.5%
6.3%
Q2 24
-46.8%
4.6%
Q1 24
-12.1%
4.1%
EPS (diluted)
CLVT
CLVT
SXC
SXC
Q4 25
$0.00
$-1.00
Q3 25
$-0.04
$0.26
Q2 25
$-0.11
$0.02
Q1 25
$-0.15
$0.20
Q4 24
$-0.27
$0.28
Q3 24
$-0.09
$0.36
Q2 24
$-0.46
$0.25
Q1 24
$-0.14
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
SXC
SXC
Cash + ST InvestmentsLiquidity on hand
$329.2M
$88.7M
Total DebtLower is stronger
$4.3B
$685.5M
Stockholders' EquityBook value
$4.8B
$597.3M
Total Assets
$11.1B
$1.8B
Debt / EquityLower = less leverage
0.89×
1.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
SXC
SXC
Q4 25
$329.2M
$88.7M
Q3 25
$318.7M
$80.4M
Q2 25
$362.6M
$186.2M
Q1 25
$354.0M
$193.7M
Q4 24
$295.2M
$189.6M
Q3 24
$388.5M
$164.7M
Q2 24
$376.4M
$81.9M
Q1 24
$361.8M
$120.1M
Total Debt
CLVT
CLVT
SXC
SXC
Q4 25
$4.3B
$685.5M
Q3 25
$4.4B
$691.1M
Q2 25
$4.5B
$493.4M
Q1 25
$4.5B
$492.9M
Q4 24
$4.5B
$492.3M
Q3 24
$4.6B
$491.8M
Q2 24
$4.6B
$491.3M
Q1 24
$4.6B
$490.8M
Stockholders' Equity
CLVT
CLVT
SXC
SXC
Q4 25
$4.8B
$597.3M
Q3 25
$4.9B
$695.9M
Q2 25
$5.0B
$677.7M
Q1 25
$5.0B
$684.6M
Q4 24
$5.1B
$680.2M
Q3 24
$5.5B
$658.6M
Q2 24
$5.6B
$636.9M
Q1 24
$5.9B
$623.0M
Total Assets
CLVT
CLVT
SXC
SXC
Q4 25
$11.1B
$1.8B
Q3 25
$11.2B
$1.9B
Q2 25
$11.4B
$1.6B
Q1 25
$11.5B
$1.7B
Q4 24
$11.5B
$1.7B
Q3 24
$12.0B
$1.7B
Q2 24
$12.1B
$1.7B
Q1 24
$12.5B
$1.7B
Debt / Equity
CLVT
CLVT
SXC
SXC
Q4 25
0.89×
1.15×
Q3 25
0.90×
0.99×
Q2 25
0.90×
0.73×
Q1 25
0.90×
0.72×
Q4 24
0.88×
0.72×
Q3 24
0.84×
0.75×
Q2 24
0.83×
0.77×
Q1 24
0.79×
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
SXC
SXC
Operating Cash FlowLast quarter
$159.9M
$56.6M
Free Cash FlowOCF − Capex
$89.2M
$32.8M
FCF MarginFCF / Revenue
14.5%
6.8%
Capex IntensityCapex / Revenue
11.5%
5.0%
Cash ConversionOCF / Net Profit
51.58×
TTM Free Cash FlowTrailing 4 quarters
$365.3M
$42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
SXC
SXC
Q4 25
$159.9M
$56.6M
Q3 25
$181.1M
$9.2M
Q2 25
$116.3M
$17.5M
Q1 25
$171.2M
$25.8M
Q4 24
$141.3M
$60.9M
Q3 24
$202.9M
$107.2M
Q2 24
$126.2M
$-9.3M
Q1 24
$176.2M
$10.0M
Free Cash Flow
CLVT
CLVT
SXC
SXC
Q4 25
$89.2M
$32.8M
Q3 25
$115.5M
$-16.3M
Q2 25
$50.3M
$4.9M
Q1 25
$110.3M
$20.9M
Q4 24
$59.1M
$36.1M
Q3 24
$126.3M
$92.1M
Q2 24
$60.3M
$-26.8M
Q1 24
$111.8M
$-5.5M
FCF Margin
CLVT
CLVT
SXC
SXC
Q4 25
14.5%
6.8%
Q3 25
18.5%
-3.3%
Q2 25
8.1%
1.1%
Q1 25
18.6%
4.8%
Q4 24
8.9%
7.4%
Q3 24
20.3%
18.8%
Q2 24
9.3%
-5.7%
Q1 24
18.0%
-1.1%
Capex Intensity
CLVT
CLVT
SXC
SXC
Q4 25
11.5%
5.0%
Q3 25
10.5%
5.2%
Q2 25
10.6%
2.9%
Q1 25
10.3%
1.1%
Q4 24
12.4%
5.1%
Q3 24
12.3%
3.1%
Q2 24
10.1%
3.7%
Q1 24
10.4%
3.2%
Cash Conversion
CLVT
CLVT
SXC
SXC
Q4 25
51.58×
Q3 25
0.41×
Q2 25
9.21×
Q1 25
1.49×
Q4 24
2.57×
Q3 24
3.49×
Q2 24
-0.43×
Q1 24
0.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Academia Government Group$312.3M51%
Re Occurring Revenues$114.1M18%
Life Sciences And Healthcare Group$98.3M16%
Transactional Revenues$97.1M16%

SXC
SXC

Segment breakdown not available.

Related Comparisons